Biofrontera Inc (BFRI) is reporting earnings on Friday. Lets focus in on how the biotech stock is performing.
Share price moves can have an impact on existing shareholder sentiment. As of August 04 shares of BFRI are trading at $1.45. Over the last 52-week period, the price is down -90.09%, which could spell for a strong bearish attitude with investors.
An EPS (earnings per share) of -$0.34 is expected to be reported by Biofrontera Inc according to analyst consensus. Over the last 90 days, analysts have revised estimates downwards once.
If you're a bull you'll primarily care about three things. The first is that the reported EPS beat analysts estimates. The second is that the beat is on higher than expected revenues. Third, that the company guides analysts to robust growth going forward. If all check out, the stock should react accordingly.
If you're a bear you'll primarily care about two things. The first is that the reported EPS underperformed analysts estimates. The stock should move on just that news alone. The second is that the report paints a pretty depressing picture of how the company will decelerate or even see a decline in revenues over the following quarters. EPS underperformance, and a negative growth story, those are the things to watch.
Regardless of which side of the fence you're on, it's important to note that sometimes the company's earnings report plays less of a role in moving the price than the analysts' estimates. This can be caused by a change in the analysts' estimates based on the Q&A from the conference call with management discussing the earnings report.